Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Stoke Therapeutics, Inc. | 29,747 | reported | 03 Jun 2025 | tx 15+17,295,522−15,397,824 |
| Eledon Pharmaceuticals, Inc. | 12,000 | reported | 15 Jun 2016 | tx 12+7,936,070−79,044,007 |
| Akero Therapeutics, Inc. | 0 | reported | 09 Dec 2025 | tx 44+5,947,601−14,635,051 |
| HeartWare LTD | 0 | reported | 23 Aug 2016 | tx 123+2,757,314−3,212,526 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 148,063 | — | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 136,301 | — | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 9,398 | — | |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 13,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 15,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 13,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 15,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 26,000 | — | deriv |
| 09 Dec 2025 | OTHER | Akero Therapeutics, Inc. | 26,000 | — | deriv |
| 03 Jun 2025 | GRANT_AWARD | Akero Therapeutics, Inc. | 9,398 | 0.00 USD | |
| 03 Jun 2025 | GRANT_AWARD | Stoke Therapeutics, Inc. | 29,747 | 0.00 USD | deriv |
| 08 Jun 2024 | GRANT_AWARD | Akero Therapeutics, Inc. | 26,000 | 0.00 USD | deriv |
| 05 Jun 2024 | GRANT_AWARD | Stoke Therapeutics, Inc. | 7,639 | 0.00 USD | deriv |
| 23 Jun 2023 | GRANT_AWARD | Akero Therapeutics, Inc. | 15,000 | 0.00 USD | deriv |
| 13 Jun 2023 | GRANT_AWARD | Stoke Therapeutics, Inc. | 19,441 | 0.00 USD | deriv |
| 30 Nov 2022 | SALE | Akero Therapeutics, Inc. | 6,851 | 46.44 USD | |
| 30 Nov 2022 | SALE | Akero Therapeutics, Inc. | 5,179 | 47.60 USD | |
| 30 Nov 2022 | SALE | Akero Therapeutics, Inc. | 6,322 | 46.44 USD | |
| 30 Nov 2022 | SALE | Akero Therapeutics, Inc. | 4,779 | 47.60 USD | |
| 28 Oct 2022 | SALE | Akero Therapeutics, Inc. | 20,338 | 40.28 USD | |
| 28 Oct 2022 | SALE | Akero Therapeutics, Inc. | 800 | 41.12 USD | |
| 28 Oct 2022 | SALE | Akero Therapeutics, Inc. | 22,096 | 40.28 USD | |
| 28 Oct 2022 | SALE | Akero Therapeutics, Inc. | 869 | 41.12 USD | |
| 27 Oct 2022 | SALE | Akero Therapeutics, Inc. | 4,013 | 43.23 USD | |
| 26 Oct 2022 | SALE | Akero Therapeutics, Inc. | 20,085 | 44.90 USD |
3 purchases reported after at least 12 months of silence — most recent on 10 Jul 2020.